NCT04181164 (BABS) is a clinical trial of Microindentation in Hypophosphatasia (HPP), sponsored by Hvidovre University Hospital.

Who is sponsoring NCT04181164?

NCT04181164 is sponsored by Hvidovre University Hospital.

What drugs are being tested in NCT04181164?

Interventions in NCT04181164: Microindentation, High resolution peripheral quantitative computed tomography (HRpQCT), Biochemical analysis of different bone markers..

What condition does NCT04181164 study?

NCT04181164 studies Hypophosphatasia (HPP).

Is NCT04181164 still recruiting?

NCT04181164 is currently status unknown. Last updated 1 September 2021.

Last reviewed 2021-09-01 · How we verify

NCT04181164: BABS

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Bone Architecture and Bone Strength in Adults With Hypophosphatasia (HPP)

Status unknown Last updated 1 September 2021

What this trial tests

trial testing Microindentation in Hypophosphatasia (HPP) in 30 participants. Status unknown.

Timeline

1 October 2019

Primary endpoint
30 September 2021

30 December 2021

Quick facts

Lead sponsor	Hvidovre University Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	30
Start date	1 October 2019
Primary completion	30 September 2021
Estimated completion	30 December 2021
Sites	1 location across Denmark

Drugs / interventions tested

Microindentation
High resolution peripheral quantitative computed tomography (HRpQCT)
Biochemical analysis of different bone markers. — full drug profile →

Conditions studied

Hypophosphatasia (HPP) — all drugs for Hypophosphatasia (HPP) →

Sponsor

Hvidovre University Hospital

Who can join

18 and older, any sex, with Hypophosphatasia (HPP). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study aims to evaluate the bone architecture and bone strength in adults with Hypophosphatasia (HPP).

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Hvidovre University Hospital trials

Trials by the same sponsor.

NCT07561164 — Feasibility of a Co-designed Mobility Intervention After Hip Fracture Surgery · NA · not yet recruiting
NCT06909240 — Progressive Gait Training After First-time Deep Venous Thrombosis: Clinical Effectiveness and Involved Mecanisms (The DV · NA · recruiting
NCT07054216 — Probiotic for Infants · NA · recruiting
NCT07029334 — Effectiveness Evaluation of Social Prescribing · recruiting
NCT06789484 — Characterization of the Gastrointestinal Microbiota in Newborn Infants · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04181164 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Hvidovre University Hospital
Last refreshed: 1 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04181164.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing